Mode
Text Size
Log in / Sign up

Genetic disorders

4 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for genetic disorders

4 trials tracked for genetic disorders: 1 in phase 3 or 4.

4Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 2 Other / NA 1
  1. Phase 3 Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema Completed
  2. Phase 2 A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration Completed
  3. Phase 2 Phase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1A Completed
  4. N/A Clinical Implementation of Carrier Status Using Next Generation Sequencing Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about genetic disorders

Can genome sequencing find a diagnosis for undiagnosed genetic disorders in newborns?

Genome sequencing can find diagnoses for many undiagnosed genetic disorders in newborns, with overall success rates around 19% to 26% depending on the study and test type.

Full answer →
How might extracellular vesicles help treat premature ovarian insufficiency caused by genetic disorders?

Extracellular vesicles (EVs) offer a safer, cell-free way to treat premature ovarian insufficiency by restoring ovarian function without the risks of live cell transplants.

Full answer →
What is the diagnostic yield of exome sequencing for prenatal genetic disorders?

Exome sequencing finds a genetic cause in about 19% of prenatal cases, with higher rates for specific conditions like nonimmune hydrops fetalis.

Full answer →